Arthur A. Levin, Chief Scientific Officer at Avidity Biosciences, Inc. (RNA), sold 200 shares at $27.75 ($6K) on 2021-06-17, disclosed to the SEC on 2021-06-22.
Scheduled sale ($6k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RNA | SELL | 2025-08-08 | $5.1M | — | Filing → |
| RNA | SELL | 2025-01-23 | $107K | — | Filing → |
| RNA | SELL | 2024-11-20 | $280K | — | Filing → |